Jove
Visualize
Contact Us

Related Experiment Videos

Studies on high grade cerebral gliomas.

N M Bleehen1

  • 1University Department, Addenbrookes Hospital, Cambridge, U.K.

International Journal of Radiation Oncology, Biology, Physics
|April 1, 1990
PubMed
Summary

Attempts to improve high-grade astrocytoma treatment in the UK showed radiosensitizer misonidazole was ineffective. However, adjuvant nitrosourea therapy offered a small benefit, and a prognostic index was developed for patient stratification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Combination chemotherapy.

Proceedings of the Royal Society of Medicine·2010
Same author

RF coils for combined MR and hyperthermia studies: I. Hyperthermia applicator as an MR coil.

Magnetic resonance imaging·2001
Same author

RF coils for combined MR and hyperthermia studies: II. MR coil as an hyperthermic applicator.

Magnetic resonance imaging·2001
Same author

A medical research council randomized trial in patients with primary cerebral non-Hodgkin lymphoma: cerebral radiotherapy with and without cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy.

Cancer·2000
Same author

A magnetic resonance-compatible experimental set-up for hyperthermia studies.

Australasian radiology·2000
Same author

Simultaneous evaluation of the effects of RF hyperthermia on the intra- and extracellular tumor pH.

Magnetic resonance in medicine·2000
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Neuro-oncology
  • Clinical trial analysis
  • Cancer treatment research

Background:

  • High-grade (grades 3, 4) supratentorial astrocytomas present significant treatment challenges.
  • Previous treatment strategies in the UK aimed to enhance outcomes for these aggressive brain tumors.

Purpose of the Study:

  • To review UK-based efforts to improve treatment outcomes for high-grade astrocytomas.
  • To evaluate the efficacy of specific therapeutic agents and approaches.

Main Methods:

  • Review of clinical trial data for radiosensitizers (misonidazole).
  • Multivariate analysis of patient data to develop a prognostic index.
  • Overview of adjuvant nitrosourea therapy trials.
  • Assessment of chemosensitization by benznidazole in relapsed patients.

Main Results:

  • Misonidazole did not improve outcomes when combined with post-surgical radiotherapy.
  • A prognostic index was identified, aiding in the classification of patients with good and poor prognoses.
  • Adjuvant nitrosourea therapy trials indicated a small but significant advantage for chemotherapy.
  • Benznidazole failed to demonstrate chemosensitization effects on CCNU treatment in relapsed cases.

Conclusions:

  • Current adjuvant therapies offer limited improvement for high-grade astrocytomas.
  • Prognostic factors are crucial for stratifying patients and guiding treatment decisions.
  • Further research is needed to identify more effective treatment strategies for these tumors.

Related Experiment Videos